Montag & Associates’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-534
Closed -$21.8K 962
2025
Q1
$21.8K Hold
534
﹤0.01% 710
2024
Q4
$28.9K Hold
534
﹤0.01% 678
2024
Q3
$34.7K Hold
534
﹤0.01% 659
2024
Q2
$33.1K Hold
534
﹤0.01% 647
2024
Q1
$45.2K Hold
534
﹤0.01% 613
2023
Q4
$40K Hold
534
﹤0.01% 614
2023
Q3
$36.9K Hold
534
﹤0.01% 597
2023
Q2
$38.8K Hold
534
﹤0.01% 607
2023
Q1
$38.4K Hold
534
﹤0.01% 597
2022
Q4
$39.8K Hold
534
﹤0.01% 586
2022
Q3
$35K Hold
534
﹤0.01% 589
2022
Q2
$38K Hold
534
﹤0.01% 566
2022
Q1
$49K Buy
+534
New +$50.2K ﹤0.01% 566

Other funds holding CRI

Montag & Associates's CRI Position: Q2 2025 in Review

Montag & Associates sold out of Carter's (CRI) in Q2 2025, closing a stake of 534 shares — an estimated $21.8K sold.

Montag & Associates first reported a position in CRI in Q1 2022 and held it in 13 quarters. The position peaked at $49K in Q1 2022. 268 funds tracked by Wall St. Rank hold CRI as of Q2 2025.

  • Montag & Associates reported no remaining Carter's position as of Q2 2025 after selling out during the quarter.
  • Montag & Associates sold 534 Carter's shares in Q2 2025, an estimated $21.8K.
  • Montag & Associates first reported a position in Carter's in Q1 2022 and held it in 13 quarters.
  • Montag & Associates's Carter's position peaked at $49K in Q1 2022.
  • 268 funds tracked by Wall St. Rank held Carter's as of Q2 2025.

Based on Montag & Associates's 13F filing for Q2 2025, filed 7 Aug 2025.